Physician

Shazia Zafar, MD

According to 2025 Medicare claims, Shazia Zafar, MD (NPI: 1053522862) practices hematology/oncology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is SHAZIA ZAFAR MD LLC (NPI: 1528334414; TIN: 45-4852313) and primary practice location at 33028-3094. Zafar is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Zafar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 74 traditional Medicare patients, billed 138,402 HCPCS/CPT codes, and received $1,146,845 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,685 prescription claims across 227 beneficiaries totaling $3,233,268 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2019 DME data shows 40 claims. Open Payments data shows 29 records totaling $736. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $385,437 to $3,233,268. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	190	126,607	$1,054,251
2016	199	99,979	$848,564
2017	168	128,146	$1,381,628
2018	184	168,394	$1,874,254
2019	140	118,325	$1,434,137
2020	95	147,080	$1,571,728
2021	96	151,119	$1,778,366
2022	92	145,386	$1,847,392
2023	84	140,083	$1,379,129
2024	74	138,402	$1,146,845

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	125	671	$385,437
2016	134	743	$322,369
2017	160	877	$414,003
2018	175	996	$1,234,620
2019	156	795	$1,064,094
2020	155	809	$1,176,251
2021	168	749	$1,114,216
2022	188	866	$1,689,722
2023	202	1,185	$2,695,637
2024	227	1,685	$3,233,268

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	46	$2,402
2016	N/R	N/R	N/R
2017	N/R	12	$470
2018	N/R	12	$431
2019	N/R	40	$2,389
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	71	515	$97
99442	Telephone medical discussion with physician, 11-20 minutes	53	120	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	30	166	$62
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	27	498	$49
96372	Injection of drug or substance under skin or into muscle	34	648	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	48	1,440	$714,289
Erleada	Apalutamide	49	1,470	$702,847
Xtandi	Enzalutamide	23	690	$329,413
Venclexta	Venetoclax	13	390	$200,554
Imbruvica	Ibrutinib	30	900	$186,416

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$736	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shazia Zafar, MD?

Tedicare shows public-source Medicare data for Shazia Zafar, MD (NPI 1053522862), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shazia Zafar, MD have ACO affiliation data?

Shazia Zafar, MD is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Shazia Zafar, MD?

Shazia Zafar, MD is linked to SHAZIA ZAFAR MD LLC (billing NPI 1528334414) in the available physician profile data.

Does Shazia Zafar, MD have Open Payments data?

Shazia Zafar, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.